DNB Telecom S vs UBS Lux Equity Fund Biotech USD

DNB Telecom S vs UBS Lux Equity Fund Biotech USD

1. DNB Telecom S

  • Security

    DNB Telecom S

  • Fee

    1.20%

  • ISIN

    NO0012740192

  • Holdings

    13

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 14 holdings in DNB Telecom S, where the largest holding is T-Mobile (9.47), followed by Deutsche Telekom (9.19) and KDDI Corp (7.51). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in DNB Telecom S and UBS Lux Equity Fund Biotech USD.

DNB Telecom S UBS Lux Equity Fund Biotech USD
1. T-Mobile US Inc
USA
9.47 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Deutsche Telekom AG
Germany
9.19 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. KDDI Corp
Japan
7.51 %
3. Moderna Inc
9.21 %
4. Verizon Communications Inc
USA
5.25 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. Rogers Communications Inc
4.86 %
5. AbbVie Inc
USA
5.52 %
6. AT&T Inc
USA
4.52 %
6. Gilead Sciences Inc
USA
4.66 %
7. Nokia Oyj
4.46 %
7. Amgen Inc
4.32 %
8. Nippon Telegraph & Telephone Corp
Japan
4.4 %
8. BioNTech SE
4.13 %
9. Telefónica SA
4.32 %
9. Karuna Therapeutics Inc
3.75 %
10. Elisa Oyj
Finland
4.19 %
10. Royalty Pharma Plc
3.28 %
11. Vodafone Group ADR
3.86 %
-
12. Telenor ASA
Norway
3.69 %
-
13. SoftBank Corp
Japan
3.69 %
-

The list of fund holdings was last updated on April 17, 2025.